CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 14 enrolled
Drug / intervention
Acupressuredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05412121
NCT05412121N/ACompleted
CompareCT.gov

Feasibility and Acceptability of Acupressure in Patients With Rheumatoid Arthritis

University of Michigan·interventional·Posted Jun 9, 2022·Updated May 9, 2024

In Brief

A clinical study evaluating Acupressure for Rheumatoid Arthritis. Completed, enrolled 14 participants across 1 site.

Detailed Summary

The goal of this pilot trial is to better understand if acupressure is feasible and tolerable to people with rheumatoid arthritis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRheumatoid Arthritis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedJun 9, 2022
Enrollment StartSep 15, 2022
Primary CompletionJul 14, 2023
Study CompletionJul 20, 2023
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 4.1 years ago

Interventions

Acupressuredevice

The MeTime Acupressure app will be loaded onto computer tablets or smart phones by the participants. Participants will also receive an AcuWand to be used in association with the acupressure app to help participants apply the correct amount of pressure to acupoints. There are 9 acupressure points, totaling 27 minutes of stimulation per day. Participants will perform daily acupressure for a total of six weeks. In addition all participants will complete a battery of validated questionnaires before, during and after completion of treatment intervention.